Assessing Compliance with Reporting Requirements in European Phase II to IV Clinical Trials: A Cross-Sectional Observational Study
This cross-sectional study of 7,547 European Phase II–IV clinical trials reveals that while registration data quality on the new CTIS platform is high, sponsor compliance with legal results reporting requirements remains weak, with fewer than half of the trials legally obligated to report doing so within the required timeframe.